EBOLA VIRUS DISEASE
Clinical trials for EBOLA VIRUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new EBOLA VIRUS DISEASE trials appear
Sign up with your email to follow new studies for EBOLA VIRUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope in a pill: can a japanese flu drug beat ebola?
Disease control CompletedThis study tested a drug called favipiravir, originally developed for flu, to see if it could lower the death rate in people with Ebola. 126 patients in Guinea took high doses of the oral drug. The goal was to find a safe, easy-to-use treatment that could be given in outbreak zon…
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE2 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Ebola survivors under the microscope: what happens after recovery?
Knowledge-focused CompletedThis study followed 787 people who survived Ebola or had close contact with an infected person in the Democratic Republic of the Congo. Researchers wanted to learn about long-term health problems, how the immune system responds, and whether the virus stays in the body. No new tre…
Matched conditions: EBOLA VIRUS DISEASE
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 11, 2026 20:50 UTC